Peng P, Gong YM, Bao PP, Ke JZ, Xiang YM, Zhang ML, Zheng Y. Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33(10):1056–9.
PubMed
Google Scholar
McGregor B, Tulloch AG, Quinlan MF, Lovegrove F. The role of bone scanning in the assessment of prostatic carcinoma. Br J Urol. 1978;50(3):178–81.
Article
CAS
PubMed
Google Scholar
Briganti A, Passoni N, Ferrari M, Capitanio U, Suardi N, Gallina A, Da Pozzo LF, Picchio M, Di Girolamo V, Salonia A, et al. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. Eur Urol. 2010;57(4):551–8.
Article
PubMed
Google Scholar
Ritenour CW, Abbott JT, Goodman M, Alazraki N, Marshall FF, Issa MM. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients. ScientificWorldJournal. 2009;9:1040–5.
Article
PubMed
Google Scholar
Zaman MU, Fatima N, Sajjad Z. Metastasis on bone scan with low prostate specific antigen (</=20 ng/ml) and Gleason’s score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines? Asian Pac J Cancer Prev. 2011;12(6):1529–32.
PubMed
Google Scholar
Lai MH, Luk WH, Chan JC. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population. Urol Oncol. 2011;29(3):275–9.
Article
PubMed
Google Scholar
Hirobe M, Takahashi A, Hisasue S, Kitamura H, Kunishima Y, Masumori N, Iwasawa A, Fujimori K, Hasegawa T, Tsukamoto T. Bone scanning--who needs it among patients with newly diagnosed prostate cancer? Jpn J Clin Oncol. 2007;37(10):788–92.
Article
PubMed
Google Scholar
Lee SH, Chung MS, Park KK, Yom CD, Lee DH, Chung BH. Is it suitable to eliminate bone scan for prostate cancer patients with PSA </= 20 ng/mL? World J Urol. 2012;30(2):265–9.
Article
CAS
PubMed
Google Scholar
Wang TY, Chen XP, Li XS, Jia Y, Cheng J, Zhang JH, Cai L, Zhang Z, Gong K, He ZS, et al. Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer. Beijing Da Xue Xue Bao. 2012;44(4):528–34.
CAS
PubMed
Google Scholar
Zhou JQ, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Ye DW. Necessity analysis of bone scan in patients with newly diagnosed prostate cancer. Zhonghua Yi Xue Za Zhi. 2013;93(4):248–51.
PubMed
Google Scholar
Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243(1):28–53.
Article
PubMed
Google Scholar
Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA. 1993;269(1):57–60.
Article
CAS
PubMed
Google Scholar
Yang G, Zuo S, Ma C, Liu B, Wang G, Wang X, Wu H. The diagnostic correlations of bone scintigraphy, pathological grade and PSA for metastatic prostate cancers. Chin-Ger J Clin Oncol. 2009;8(12):702–4.
Article
CAS
Google Scholar
Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int. 2002;90(2):162–73.
Article
CAS
PubMed
Google Scholar
Man A, Pickles T, Chi KN. Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol. 2003;170(3):901–4.
Article
PubMed
Google Scholar
Zhang L, Wu S, Guo LR, Zhao XJ. Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China. Asian J Androl. 2009;11(1):9–13.
Article
PubMed
Google Scholar
Cullen J, Elsamanoudi S, Brassell SA, Chen Y, Colombo M, Srivastava A, McLeod DG. The burden of prostate cancer in Asian nations. J Carcinog. 2012;11:7.
Article
PubMed
PubMed Central
Google Scholar
Wang Y, Guo J, Xu L, Zhao N, Xu Z, Wang H, Zhu Y, Jiang S, Yang N, Yang Y, et al. Should Bone Scan be Performed in Chinese Prostate Cancer Patients at the Time of Diagnosis? Urol Int. 2013;91(2):160–4.
Davies JD, Aghazadeh MA, Phillips S, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Penson DF, et al. Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol. 2011;186(6):2221–7.
Article
PubMed
Google Scholar
Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman Jr RP, Ross JS, Jennings TA, Nazeer T. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology. 2006;67(2):379–83.
Article
PubMed
Google Scholar